Huttunen KM

References (7)

Title : Improved L-Type Amino Acid Transporter 1 (LAT1)-Mediated Delivery of Anti-Inflammatory Drugs into Astrocytes and Microglia with Reduced Prostaglandin Production - Tampio_2021_Int.J.Pharm__120565
Author(s) : Tampio J , Loffler S , Guillon M , Hugele A , Huttunen J , Huttunen KM
Ref : Int J Pharm , :120565 , 2021
PubMedID: 33812973

Title : Targeting of Perforin Inhibitor into the Brain Parenchyma Via a Prodrug Approach Can Decrease Oxidative Stress and Neuroinflammation and Improve Cell Survival - Tampio_2020_Mol.Neurobiol_57_4563
Author(s) : Tampio J , Huttunen J , Montaser A , Huttunen KM
Ref : Molecular Neurobiology , 57 :4563 , 2020
PubMedID: 32754897

Title : Astrocyte-Targeted Transporter-Utilizing Derivatives of Ferulic Acid Can Have Multifunctional Effects Ameliorating Inflammation and Oxidative Stress in the Brain - Montaser_2019_Oxid.Med.Cell.Longev_2019_3528148
Author(s) : Montaser A , Huttunen J , Ibrahim SA , Huttunen KM
Ref : Oxid Med Cell Longev , 2019 :3528148 , 2019
PubMedID: 31814871

Title : Metformin and its sulphonamide derivative simultaneously potentiate anti-cholinesterase activity of donepezil and inhibit beta-amyloid aggregation - Markowicz-Piasecka_2018_J.Enzyme.Inhib.Med.Chem_33_1309
Author(s) : Markowicz-Piasecka M , Huttunen KM , Sikora J
Ref : J Enzyme Inhib Med Chem , 33 :1309 , 2018
PubMedID: 30251898

Title : Identification of human, rat and mouse hydrolyzing enzymes bioconverting amino acid ester prodrug of ketoprofen - Huttunen_2018_Bioorg.Chem_81_494
Author(s) : Huttunen KM
Ref : Bioorg Chem , 81 :494 , 2018
PubMedID: 30243240

Title : Metformin - a Future Therapy for Neurodegenerative Diseases : Theme: Drug Discovery, Development and Delivery in Alzheimer's Disease Guest Editor: Davide Brambilla - Markowicz-Piasecka_2017_Pharm.Res_34_2614
Author(s) : Markowicz-Piasecka M , Sikora J , Szydlowska A , Skupien A , Mikiciuk-Olasik E , Huttunen KM
Ref : Pharm Res , 34 :2614 , 2017
PubMedID: 28589443

Title : Metformin and Its Sulfenamide Prodrugs Inhibit Human Cholinesterase Activity - Markowicz-Piasecka_2017_Oxid.Med.Cell.Longev_2017_7303096
Author(s) : Markowicz-Piasecka M , Sikora J , Mateusiak L , Mikiciuk-Olasik E , Huttunen KM
Ref : Oxid Med Cell Longev , 2017 :7303096 , 2017
PubMedID: 28770024